Cardlytics (CDLX) to Release Earnings on Wednesday

Cardlytics (NASDAQ:CDLXGet Free Report) is projected to announce its earnings results after the market closes on Wednesday, March 12th. Analysts expect the company to announce earnings of ($0.24) per share and revenue of $63.63 million for the quarter. Individual that wish to register for the company’s earnings conference call can do so using this link.

Cardlytics Stock Performance

NASDAQ CDLX opened at $1.81 on Tuesday. The company has a market capitalization of $91.99 million, a price-to-earnings ratio of -0.30 and a beta of 1.62. Cardlytics has a twelve month low of $1.77 and a twelve month high of $20.52. The stock has a fifty day simple moving average of $3.16 and a 200 day simple moving average of $3.55. The company has a quick ratio of 1.18, a current ratio of 1.18 and a debt-to-equity ratio of 2.40.

Insiders Place Their Bets

In other news, CFO Alexis Desieno sold 24,778 shares of the stock in a transaction dated Tuesday, February 18th. The shares were sold at an average price of $3.40, for a total transaction of $84,245.20. Following the transaction, the chief financial officer now owns 140,948 shares of the company’s stock, valued at $479,223.20. This represents a 14.95 % decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. Also, CEO Amit Gupta sold 46,857 shares of the business’s stock in a transaction dated Tuesday, February 18th. The shares were sold at an average price of $3.40, for a total value of $159,313.80. Following the completion of the sale, the chief executive officer now directly owns 418,637 shares of the company’s stock, valued at $1,423,365.80. The trade was a 10.07 % decrease in their ownership of the stock. The disclosure for this sale can be found here. In the last three months, insiders have sold 111,454 shares of company stock worth $391,864. Corporate insiders own 4.40% of the company’s stock.

Analyst Ratings Changes

Separately, Needham & Company LLC reaffirmed a “hold” rating on shares of Cardlytics in a research note on Friday, January 17th. One equities research analyst has rated the stock with a sell rating, five have given a hold rating and one has issued a strong buy rating to the company’s stock. Based on data from MarketBeat.com, the stock presently has an average rating of “Hold” and a consensus price target of $6.92.

Check Out Our Latest Report on CDLX

About Cardlytics

(Get Free Report)

Cardlytics, Inc operates an advertising platform in the United States and the United Kingdom. It offers Cardlytics platform, a proprietary native bank advertising channel that enables marketers to reach customers through their network of financial institution partners through digital channels, such as online, mobile applications, email, and various real-time notifications; and Bridg platform, a customer data platform which utilizes point-of-sale data and enables marketers to perform analytics and targeted loyalty marketing, as well as measure the impact of their marketing.

Featured Stories

Earnings History for Cardlytics (NASDAQ:CDLX)

Receive News & Ratings for Cardlytics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cardlytics and related companies with MarketBeat.com's FREE daily email newsletter.